Skip to main content
×

Cookie Notification

We use cookies to collect information about how our website is used and to improve the visitor experience. You can change your browser's cookie settings at any time. Please review our privacy policy for more information. OK

This website is intended for a global audience.

Home
  • About Us
    • History & Approach
    • Board of Directors
    • Executive Leadership
    • Company Values & Code of Conduct
    • News
  • Healthcare Professionals
    • Research & Trials
      • Therapeutic Areas
      • Cannabinoid Compounds
      • CBD Mechanism of Action
      • Research Papers
    • Pipeline
    • Epidiolex®
    • Sativex®
      • MS Spasticity
      • Information on Obtaining Sativex®
  • Patients & Caregivers
    • Sativex® Patient Information
  • Investors & Media
    • Financial Report
    • SEC Filings
    • Stock Information
    • Analyst Coverage
    • Press Releases
    • Events & Presentations
    • Shareholder Services
    • AIM de-list
      • AIM de-list FAQ
      • Conversion of Ordinary shares into ADRs
      • Suggested Broker Contact for conversion of Ordinary Shares to ADRs
    • Shareholder FAQs
    • Securities In Issue
    • Advisers
    • Corporate Governance
      • Board of Directors
      • Executive Leadership
      • Disclosure Policy
      • Code of Conduct and Business Ethics
    • IR Contacts
  • Careers
    • UK Careers
    • US Careers
  • Contact Us
    • Select a Region
    • European
    • Global Corporate
    • United States (US)

GW Pharmaceuticals is Honored to be Named As One of TIME’S 50 Genius Companies For Its Work in Advancing Cannabinoid Science

Committed to making a difference

  1. Home
  2. Home

Home

About Us

Girl Smiling

GW is the global leader in developing cannabinoid-based medicines.

READ MORE >

Healthcare Professionals

Boy and Mother Looking at Something

GW has been researching cannabinoids since 1998 and has established a world leading position in the development of plant-derived cannabinoid therapeutics.

READ MORE >

Patients & Caregivers

Girl Blowing Bubbles

"GW's vision is to be the global leader in prescription cannabinoid medicines, developing and commercializing pharmaceutical products which address clear unmet needs." >


-Justin Gover,
Chief Executive Officer

Investors & Media

Arlo and his mother

Click here to view Investors Relations section. >

Careers

Boy Looking at Something

Join GW Pharmaceuticals where you can positively impact the lives of patients. >

Recent News

Girl Blowing Bubbles
Dec 07, 2019
Greenwich Biosciences, a GW Pharmaceuticals Company, Presents New Data for EPIDIOLEX® (cannabidiol) in Patients with Tuberous Sclerosis Complex (TSC) at the American Epilepsy Society Annual Meeting
Read More >

Contact Us

Footer

  • Home
  • About Us
  • Healthcare Professionals
  • Patients & Caregivers
  • Investors & Media
  • Careers
  • Contact Us
  • Legal

GW Pharmaceuticals plc. All rights reserved

GWP-04748

This section of the website is reserved for healthcare professionals as it contains information about prescription medicines. Please confirm you are a healthcare professional to continue.

YES, I AM A HEALTHCARE PROFESSIONAL

NO, I AM NOT A HEALTHCARE PROFESSIONAL

Please note, you are now leaving www.gwpharm.com

OK

STAY ON SITE